Miura S, Ueda T, Jimbow K, Ito S, Fujita K
Department of Dermatology, Sapporo Medical College, Japan.
Arch Dermatol Res. 1987;279(4):219-25. doi: 10.1007/BF00417318.
Phenolic and catecholic compounds were synthesized, by combination with cysteine or cysteamine through thioether bond, and their antimelanoma and melanocytotoxic effects were evaluated. Among nine compounds tested, 4-S-cysteaminylphenol (CAP) resulted in an increase in the life span (% ILS) of melanoma-bearing mice and in the growth inhibition (% GI) of melanoma tissue. 4-S-Cysteinylphenol (CP) and its methyl ester form also showed some increase in % GI. The 2-S-isomers of CP and CAP and diphenolic derivatives of CP did not show any significant antimelanoma effect. In addition, the s.c. injection of 4-S-CAP and 4-S-CP, in particular 4-S-CAP, caused the depigmentation of black hair which was manifested by loss of functioning melanocytes, as seen under light microscopy. The 4-S-CAP appears to provide a basis for development of a new class of antimelanoma and melanocytotoxic agents that are more stable than catecholic compounds, which have been most widely utilized as a source of rational chemotherapy for malignant melanoma.
通过硫醚键与半胱氨酸或半胱胺结合合成了酚类和儿茶酚类化合物,并评估了它们的抗黑色素瘤和黑色素细胞毒性作用。在所测试的九种化合物中,4-S-半胱胺基苯酚(CAP)使荷黑色素瘤小鼠的寿命延长(寿命延长百分比,%ILS),并使黑色素瘤组织的生长受到抑制(生长抑制百分比,%GI)。4-S-半胱氨酸基苯酚(CP)及其甲酯形式也显示出一定程度的%GI增加。CP和CAP的2-S-异构体以及CP的二酚衍生物未显示出任何显著的抗黑色素瘤作用。此外,皮下注射4-S-CAP和4-S-CP,特别是4-S-CAP,导致黑色毛发脱色,这在光学显微镜下表现为功能性黑色素细胞的丧失。4-S-CAP似乎为开发一类新型的抗黑色素瘤和黑色素细胞毒性药物提供了基础,这类药物比儿茶酚类化合物更稳定,儿茶酚类化合物已被最广泛地用作恶性黑色素瘤合理化疗的来源。